The US Centers for Disease Control and Prevention (CDC) has endorsed recommendation from its vaccine advisers for use of the Moderna Covid-19 vaccine for people ages 18 years and older.
The recommendation came after the US Food and Drug Administration (FDA) on Monday granted full approval to the Moderna Covid-19 vaccine, Xinhua news agency reported.
"We now have another fully approved Covid-19 vaccine," said CDC Director Rochelle Walensky in a statement.
"If you have been waiting for approval before getting vaccinated, now is the time to join the nearly 212 million Americans who have already completed their primary series. CDC continues to recommend that people remain up to date on their Covid-19 vaccines, including getting a booster shot when eligible," she said.
Earlier on Friday, the CDC's vaccine advisers voted unanimously to recommend the two-dose Moderna Covid-19 vaccine for people ages 18 years and older.
The vaccine, named Spikevax, joins Pfizer-BioNTech's formulation as the two fully-approved Covid-19 vaccines in the United States.
The full approval suggests Spikevax meets the FDA's rigorous standards for safety, effectiveness and manufacturing quality.
--IANS
int/shs
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)